Core Viewpoint - The law firm Junzejun has conducted a special verification of the stock trading activities of insiders related to the asset acquisition and related transactions of Meinian Health Industry Holdings Co., Ltd, confirming that no insider trading occurred during the self-examination period [1][11]. Group 1: Transaction Overview - Meinian Health has engaged Junzejun Law Firm to provide legal advice and issue a legal opinion regarding its issuance of shares for asset acquisition and related transactions [1][2]. - The self-examination period for insider trading activities spans from six months prior to the initial disclosure of the transaction plan until one day before the report was disclosed, specifically from April 14, 2024, to July 11, 2025 [3][4]. Group 2: Insider Trading Verification - The verification scope includes insiders and their immediate family members, such as spouses and children, who are involved in the stock trading activities during the self-examination period [4]. - A total of 33 individuals were identified as having engaged in stock trading activities during the self-examination period, with specific details on their trading activities documented [6][7]. Group 3: Compliance and Commitments - The law firm confirmed that the trading activities of the identified insiders and their family members were based on personal investment decisions and did not involve any insider information related to the transaction [10][11]. - Insiders have provided written commitments stating that their trading activities were independent and did not constitute insider trading, agreeing to forfeit any profits if found to be in violation of regulations [9][10].
美年健康: 北京市君泽君律师事务所关于美年大健康产业控股股份有限公司发行股份购买资产暨关联交易相关主体买卖股票情况自查报告的专项核查意见